nach oben

Erschienen in:

01.06.2015 | Original Article

Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases

Local tumour control and survival

verfasst von: Dr. med. Dr. rer. nat. Oliver Oehlke, MD, PhD, David Wucherpfennig, Dr. med. Franziska Fels, MD, Dr. phil. Lars Frings, PhD, Dr. med. Karl Egger, MD, PD Dr. med. Astrid Weyerbrock, MD, PD Dr. rer. nat. Vesna Prokic, PhD, Prof. Dr. med. Carsten Nieder, MD, Prof. Dr. med. Anca-Ligia Grosu, MD

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Hippocampal-avoidance whole brain radiotherapy (HA-WBRT) for multiple brain metastases may prevent treatment-related cognitive decline, compared to standard WBRT. Additionally, simultaneous integrated boost (SIB) on individual metastases may further improve the outcome. Here, we present initial data concerning local tumour control (LTC), intracranial progression-free survival (PFS), overall survival (OS), toxicity and safety for this new irradiation technique.

Methods and materials

Twenty patients, enrolled between 2011 and 2013, were treated with HA-WBRT (30 Gy in 12 fractions, D_98 % to hippocampus ≤ 9 Gy) and a SIB (51 Gy) on multiple (2–13) metastases using a volumetric modulated arc therapy (VMAT) approach based on 2–4 arcs. Metastases were evaluated bidimensionally along the two largest diameters in contrast-enhanced three-dimensional T1-weighed MRI.

Results

Median follow-up was 40 weeks. The median time to progression of boosted metastases has not been reached yet, corresponding to a LTC rate of 73 %. Median intracranial PFS was 40 weeks, corresponding to a 1-year PFS of 45.3 %. Median OS was 71.5 weeks, corresponding to a 1-year OS of 60 %. No obvious acute or late toxicities grade > 2 (NCI CTCAE v4.03) were observed. D_mean to the bilateral hippocampi was 6.585 Gy ± 0.847 (α/β = 2 Gy). Two patients developed a new metastasis in the area of hippocampal avoidance.

Conclusion

HA-WBRT (simultaneous integrated protection, SIP) with SIB to metastases is a safe and tolerable regime that shows favorable LTC for patients with multiple brain metastases, while it has the potential to minimize the side-effect of cognitive deterioration.

Cairncross JG, Kim JH, Posner JB (1980) Radiation therapy for brain metastases. Ann Neurol 7:529–541CrossRefPubMed

Weissman DE (1988) Glucocorticoid treatment for brain metastases and epidural spinal cord compression: a review. J Clin Oncol 6:543–551PubMed

Diener-West M, Dobbins TW, Phillips TL, Nelson DF (1989) Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG study 7916. Int J Radiat Oncol Biol Phys 16:669–673CrossRefPubMed

Kondziolka D, Patel A, Lunsford LD et al (1999) Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 45:427–434CrossRefPubMed

Kocher M, Soffietti R, Abacioglu U et al (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952–26001 study. J Clin Oncol 29:134–141CrossRefPubMedCentralPubMed

Li J, Bentzen SM, Li J, Renschler M, Mehta MP (2008) Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis. Int J Radiat Oncol Biol Phys 71:64–70CrossRefPubMed

Soffietti R, Kocher M, Abacioglu UM et al (2013) A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol 31:65–72CrossRefPubMed

Roman DD, Sperduto PW (1995) Neuropsychological effects of cranial radiation: current knowledge and future directions. Int J Radiat Oncol Biol Phys 31:983–998CrossRefPubMed

Welzel G, Fleckenstein K, Schaefer J et al (2008) Memory function before and after whole brain radiotherapy in patients with and without brain metastases. Int J Radiat Oncol Biol Phys 72:1311–1318CrossRefPubMed

10.

Chang EL, Wefel JS, Hess KR et al (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:1037–1044CrossRefPubMed

11.

Taphoorn MJ, Klein M (2004) Cognitive deficits in adult patients with brain tumours. Lancet Neurol 3:159–168CrossRefPubMed

12.

Milner B, Squire LR, Kandel ER (1998) Cognitive neuroscience and the study of memory. Neuron 20:445–468CrossRefPubMed

13.

Dickerson BC, Eichenbaum H (2010) The episodic memory system: neurocircuitry and disorders. Neuropsychopharmacology 35:86–104CrossRefPubMedCentralPubMed

14.

Scoville WB, Milner B (1957) Loss of recent memory after bilateral hippocampal lesions. J Neurol Neurosurg Psychiatry 20:11–21CrossRefPubMedCentralPubMed

15.

Shors TJ, Miesegaes G, Beylin A et al (2001) Neurogenesis in the adult is involved in the formation of trace memories. Nature 410:372–376CrossRefPubMed

16.

Deng W, Aimone JB, Gage FH (2010) New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory? Nat Rev Neurosci 11:339–350CrossRefPubMedCentralPubMed

17.

Small SA, Schobel SA, Buxton RB et al (2011) A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat Rev Neurosci 12:585–601CrossRefPubMedCentralPubMed

18.

Gondi V, Tome WA, Marsh J et al (2010) Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy: safety profile for RTOG 0933. Radiother Oncol 95:327–331CrossRefPubMedCentralPubMed

19.

Oskan F, Ganswindt U, Schwarz SB et al (2014) Hippocampus sparing in whole-brain radiotherapy. A review. Strahlenther Onkol 190:337–341CrossRefPubMed

20.

Assouline A, Levy A, Chargari C et al (2011) Whole brain radiotherapy: prognostic factors and results of a radiation boost delivered through a conventional linear accelerator. Radiother Oncol 99:214–217CrossRefPubMed

21.

Casanova N, Mazouni Z, Bieri S et al (2010) Whole brain radiotherapy with a conformational external beam radiation boost for lung cancer patients with 1–3 brain metastasis: a multi institutional study. Radiat Oncol 5:13CrossRefPubMedCentralPubMed

22.

Prokic V, Wiedenmann N, Fels F et al (2013) Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: a planning study on treatment concepts. Int J Radiat Oncol Biol Phys 85:264-270

23.

Broemme J, Abu-Isa J, Kottke R et al (2013) Adjuvant therapy after resection of brain metastases. Frameless image-guided LINAC-based radiosurgery and stereotactic hypofractionated radiotherapy. Strahlenther Onkol 189:765–770CrossRefPubMed

24.

Brant-Zawadzki M, Gillan GD, Nitz WR (1992) MP RAGE: a three-dimensional, T1-weighted, gradient-echo sequence–initial experience in the brain. Radiology 182:769–775CrossRefPubMed

25.

Lin NU, Lee EQ, Aoyama H et al (2013) Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group. Lancet Oncol 14:e396–e406CrossRefPubMed

26.

Monje ML, Mizumatsu S, Fike JR, Palmer TD (2002) Irradiation induces neural precursor-cell dysfunction. Nat Med 8:955–962CrossRefPubMed

27.

Dietrich J, Monje M, Wefel J, Meyers C (2008) Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. Oncologist 13:1285–1295CrossRefPubMed

28.

Gondi V, Pugh SL, Tome WA et al (2014) Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. J Clin Oncol 32:3810–3816CrossRefPubMed

29.

Harth S, Abo-Madyan Y, Zheng L et al (2013) Estimation of intracranial failure risk following hippocampal-sparing whole brain radiotherapy. Radiother Oncol 109:152–158CrossRefPubMed

30.

Gondi V, Hermann BP, Mehta MP, Tomé WA (2013) Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors. Int J Radiat Oncol Biol Phys 85:348–354CrossRefPubMed

31.

Rades D, Pluemer A, Veninga T et al (2007) A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients. Cancer 110:1551–1559CrossRefPubMed

32.

Andrews DW, Scott CB, Sperduto PW et al (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363:1665–1672CrossRefPubMed

33.

Yamamoto M, Serizawa T, Shuto T et al (2014) Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol 15:387–395CrossRefPubMed

34.

Wiggenraad R, Verbeek-de Kanter A, Mast M et al (2012) Local progression and pseudo progression after single fraction or fractionated stereotactic radiotherapy for large brain metastases. A single centre study. Strahlenther Onkol 188:696–701CrossRefPubMed

35.

Lawrence YR, Li XA, el Naqa I et al (2010) Radiation dose–volume effects in the brain. Int J Radiat Oncol Biol Phys 76:S20–S27CrossRefPubMedCentralPubMed

36.

Awad R, Fogarty G, Hong A et al (2013) Hippocampal avoidance with volumetric modulated arc therapy in melanoma brain metastases—the first Australian experience. Radiat Oncol 8:62CrossRefPubMedCentralPubMed

37.

Rades D, Gerdan L, Segedin B et al (2013) Brain metastasis. Prognostic value of the number of involved extracranial organs. Strahlenther Onkol 189:996–1000CrossRefPubMed

38.

Gaspar L, Scott C, Rotman M et al (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745–751CrossRefPubMed

Titel: Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases
Local tumour control and survival
verfasst von: Dr. med. Dr. rer. nat. Oliver Oehlke, MD, PhD
David Wucherpfennig
Dr. med. Franziska Fels, MD
Dr. phil. Lars Frings, PhD
Dr. med. Karl Egger, MD
PD Dr. med. Astrid Weyerbrock, MD
PD Dr. rer. nat. Vesna Prokic, PhD
Prof. Dr. med. Carsten Nieder, MD
Prof. Dr. med. Anca-Ligia Grosu, MD
Publikationsdatum: 01.06.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: Strahlentherapie und Onkologie / Ausgabe 6/2015
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-014-0808-9

Neu im Fachgebiet Onkologie

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases

Local tumour control and survival

Abstract

Purpose

Methods and materials

Results

Conclusion

Neu im Fachgebiet Onkologie

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Stufenschema weist Prostatakarzinom zuverlässig nach

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose

Methods and materials

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2015

Prognostischer Vorteil durch postoperative Strahlentherapie zusätzlich zur adjuvanten Chemotherapie bei nicht-kleinzelligen Bronchialkarzinomen im Stadium IIIA/N2

Reirradiation for recurrent head and neck cancer with salvage interstitial pulsed-dose-rate brachytherapy

Intracranial stereotactic radiosurgery with an adapted linear accelerator vs. robotic radiosurgery

Residual deficits in quality of life one year after intensity-modulated radiotherapy for patients with locally advanced head and neck cancer

Effect of the coffee ingredient cafestol on head and neck squamous cell carcinoma cell lines

Primary radiotherapy or postoperative radiotherapy in patients with head and neck cancer

Neu im Fachgebiet Onkologie

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Stufenschema weist Prostatakarzinom zuverlässig nach

Update Onkologie